← Back to Search

Activity-based Companion Care for Dementia (MEMORI Corps Trial)

N/A
Recruiting
Led By Quincy Samus, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have an established physician clinical diagnosis of dementia (any stage) and confirmed with the Clinical Dementia Rating Scale of >0.5
PWD must be able to participate in >2 basic Activities of Daily Living
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

MEMORI Corps Trial Summary

This trial is testing whether a 12-week program delivered by older volunteers can help people with dementia and their caregivers. The volunteers will either serve in the program immediately (active duty) or after a 12-week waitlist period (control group).

Who is the study for?
This trial is for English-speaking pairs of people with dementia (PWD) and their informal caregivers (CG) living in Baltimore City or County. PWD should be diagnosed with dementia, able to do some daily activities, and not have had formal respite care recently. Caregivers must live with the PWD and assist them. Volunteers aged 55+ who pass health checks can also join.Check my eligibility
What is being tested?
The MEMORI Corps program matches trained senior volunteers with dementia patients and caregivers for a 12-week period to provide activity-based companion care. The study compares this intervention against an augmented waitlist control group to assess its effectiveness.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like companionship and activities, there are no direct medical side effects expected from participation in the MEMORI Corps program.

MEMORI Corps Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with dementia, confirmed by a specific test score above 0.5.
Select...
I can perform more than two basic daily activities on my own.
Select...
I am over 18 and considered a dependable caregiver.
Select...
I live with and help someone with daily activities.
Select...
I am 55 or older, can read, have no criminal record, passed health checks, have a car, and can travel locally.
Select...
I have a good memory and thinking ability, can complete tasks quickly, and can commit to a year of service.

MEMORI Corps Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Gait speed
Change in activity engagement as assessed by the Community Healthy Activities Model Program for Seniors activity questionnaire
Change in depressive symptoms in caregivers as assessed by The Patient Health Questionnaire (PHQ) - 9
+5 more
Secondary outcome measures
Change in depressive symptoms in senior companion volunteers as assessed by The Patient Health Questionnaire (PHQ) - 9
Change in home and community-based long term services and supports use health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey
Change in objective caregiver burden as assessed by time estimates in performing tasks
+3 more

MEMORI Corps Trial Design

2Treatment groups
Experimental Treatment
Group I: ControlExperimental Treatment1 Intervention
Augmented waitlist control.
Group II: Active InterventionExperimental Treatment1 Intervention
Intervention arm with MEMORI Corps program

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,258 Previous Clinical Trials
14,819,973 Total Patients Enrolled
31 Trials studying Dementia
82,242 Patients Enrolled for Dementia
Alzheimer's AssociationOTHER
89 Previous Clinical Trials
40,203 Total Patients Enrolled
31 Trials studying Dementia
31,834 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,004,554 Total Patients Enrolled
265 Trials studying Dementia
23,622,851 Patients Enrolled for Dementia

Media Library

MEMORI Corps program Clinical Trial Eligibility Overview. Trial Name: NCT03896711 — N/A
Dementia Research Study Groups: Active Intervention, Control
Dementia Clinical Trial 2023: MEMORI Corps program Highlights & Side Effects. Trial Name: NCT03896711 — N/A
MEMORI Corps program 2023 Treatment Timeline for Medical Study. Trial Name: NCT03896711 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age restriction for this experiment preclude individuals younger than fifty?

"According to the criteria for inclusion, individuals aged between 18 and 115 are eligible to enrol in this trial."

Answered by AI

Could I potentially join this trial as a volunteer?

"To become a part of this trial, individuals must have dementia and be between 18-115 years old. A total of 560 participants need to be enrolled in the study."

Answered by AI

How many participants are being recruited for this medical experiment?

"Affirmative. The information hosted on clinicaltrials.gov affirms that this medical investigation, which was initially brought to light on October 1st 2021, is currently searching for volunteers. A total of 560 individuals need to be found from a single site."

Answered by AI

What goals is this research endeavor attempting to accomplish?

"The primary indicator of success in this study, which is monitored over a baseline to 12 week period, will be the shift in quality of life as assessed by the Quality of Life in Alzheimer's disease (QOL-AD) tool. Other data points tracked throughout include changes regarding utilization of outpatient medical services and home/community based long term services; along with stress levels measured through the Elders Life Stress Inventory (range 0-31)."

Answered by AI

Are any new participants being accepted for enrollment in this trial?

"As per information on clinicaltrials.gov, the recruitment process is ongoing for this study which was first posted in October 2021 and underwent its most recent update a year later."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
How old are they?
18 - 65
What site did they apply to?
Johns Hopkins University
What portion of applicants met pre-screening criteria?
Met criteria
~93 spots leftby Sep 2024